2型糖尿病与癌症死亡风险的关联:亚洲队列联盟超过77.1万人的汇总分析
该研究汇总了亚洲队列联盟19个前瞻性人群队列,纳入658,611名东亚人和112,686名南亚人,中位随访12.7年,比较基线糖尿病与非糖尿病者的任何癌症及部位特异性癌症死亡风险。基线糖尿病与任何癌症死亡风险增加相关(HR 1.26;95% CI 1.21,1.31),并与结直肠癌、肝癌、胆管癌、胆囊癌、胰腺癌、乳腺癌、子宫内膜癌、卵巢癌、前列腺癌、肾癌、甲状腺癌及淋巴瘤死亡风险呈显著正相关,与白血病、膀胱癌、宫颈癌、食管癌、胃癌和肺癌死亡风险无显著关联。
要点
- 在亚洲人群中,基线糖尿病与任何癌症死亡风险增加26%相关(HR 1.26;95% CI 1.21,1.31)。
- 糖尿病与肝癌(HR 2.05)、子宫内膜癌(HR 2.73)、甲状腺癌(HR 1.99)、肾癌(HR 1.84)、乳腺癌(HR 1.72)等死亡风险显著正相关。
- 糖尿病与白血病、膀胱癌、宫颈癌、食管癌、胃癌和肺癌死亡风险无显著关联。
核心结论
- 在亚洲人群中,糖尿病与任何癌症死亡风险增加26%相关(HR 1.26;95% CI 1.21,1.31)。
- 作者认为,与特定癌症的关联模式提示需要更好地控制(预防、检测、管理)日益流行的糖尿病(以及肥胖),以降低癌症死亡率。
研究设计与样本
- 研究为亚洲队列联盟19个前瞻性人群队列的汇总分析,包括658,611名东亚人和112,686名南亚人。
- 研究使用HR比较基线糖尿病者与非糖尿病者任何癌症及部位特异性癌症的死亡风险,包括食管癌、胃癌、结直肠癌、结肠癌、直肠癌、肝癌、胆管癌、胰腺癌、肺癌、乳腺癌、子宫内膜癌、宫颈癌、卵巢癌、前列腺癌、膀胱癌、肾癌、甲状腺癌、淋巴瘤和白血病。
主要发现
- 平均随访12.7年期间,共确定37,343例癌症死亡(东亚人36,667例,南亚人676例)。
- 基线糖尿病与任何癌症死亡风险增加显著相关(HR 1.26;95% CI 1.21,1.31)。
- 糖尿病与以下癌症死亡风险呈显著正相关:结直肠癌(HR 1.41;95% CI 1.26,1.57)、肝癌(HR 2.05;95% CI 1.77,2.38)、胆管癌(HR 1.41;95% CI 1.04,1.92)、胆囊癌(HR 1.33;95% CI 1.10,1.61)、胰腺癌(HR 1.53;95% CI 1.32,1.77)、乳腺癌(HR 1.72;95% CI 1.34,2.19)、子宫内膜癌(HR 2.73;95% CI 1.53,4.85)、卵巢癌(HR 1.60;95% CI 1.06,2.42)、前列腺癌(HR 1.41;95% CI 1.09,1.82)、肾癌(HR 1.84;95% CI 1.28,2.64)和甲状腺癌(HR 1.99;95% CI 1.03,3.86),以及淋巴瘤(HR 1.39;95% CI 1.04,1.86)。
- 糖尿病与白血病及膀胱癌、宫颈癌、食管癌、胃癌和肺癌死亡风险无显著关联。
临床怎么用
- 作者认为,与特定癌症的关联模式提示需要更好地控制(预防、检测、管理)日益流行的糖尿病(以及肥胖),以降低癌症死亡率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: The aims of the study were to evaluate the association between type 2 diabetes and the risk of death from any cancer and specific cancers in East and South Asians. METHODS: Pooled analyses were conducted of 19 prospective population-based cohorts included in the Asia Cohort Consortium, comprising data from 658,611 East Asians and 112,686 South Asians. HRs were used to compare individuals with diabetes at baseline with those without diabetes for the risk of death from any cancer and from site-specific cancers, including cancers of the oesophagus, stomach, colorectum, colon, rectum, liver, bile duct, pancreas, lung, breast, endometrium, cervix, ovary, prostate, bladder, kidney and thyroid, as well as lymphoma and leukaemia. RESULTS: During a mean follow-up of 12.7 years, 37,343 cancer deaths (36,667 in East Asians and 676 in South Asians) were identified. Baseline diabetes status was statistically significantly associated with an increased risk of death from any cancer (HR 1.26; 95% CI 1.21, 1.31). Significant positive associations with diabetes were observed for cancers of the colorectum (HR 1.41; 95% CI 1.26, 1.57), liver (HR 2.05; 95% CI 1.77, 2.38), bile duct (HR 1.41; 95% CI 1.04, 1.92), gallbladder (HR 1.33; 95% CI 1.10, 1.61), pancreas (HR 1.53; 95% CI 1.32, 1.77), breast (HR 1.72; 95% CI 1.34, 2.19), endometrium (HR 2.73; 95% CI 1.53, 4.85), ovary (HR 1.60; 95% CI 1.06, 2.42), prostate (HR 1.41; 95% CI 1.09, 1.82), kidney (HR 1.84; 95% CI 1.28, 2.64) and thyroid (HR 1.99; 95% CI 1.03, 3.86), as well as lymphoma (HR 1.39; 95% CI 1.04, 1.86). Diabetes was not statistically significantly associated with the risk of death from leukaemia and cancers of the bladder, cervix, oesophagus, stomach and lung. CONCLUSIONS/INTERPRETATION: Diabetes was associated with a 26% increased risk of death from any cancer in Asians. The pattern of associations with specific cancers suggests the need for better control (prevention, detection, management) of the growing epidemic of diabetes (as well as obesity), in order to reduce cancer mortality.
引用
- Chen Y, Wu F, Saito E, et al. Association between type 2 diabetes and risk of cancer mortality: a pooled analysis of over 771,000 individuals in the Asia Cohort Consortium. Diabetologia. 2017. PMID: 28265721. doi:10.1007/s00125-017-4229-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。